Post, M <br/><br/>
Immunosuppression with low-dose daclizumab in liver transplant recipients with impaired kidney function: a single-center experience.  [electronic resource] 

 -  Transplantation proceedings  Oct 2009 
 - 3107-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2009.07.096  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Creatinine--blood<br/>Daclizumab<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Diseases--epidemiology<br/>Length of Stay<br/>Liver Diseases--classification<br/>Liver Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Prednisolone--therapeutic use<br/>Retrospective Studies